Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-β inhibitor

Lisa J. Green, Philip Marder, Chad Ray, Carolyn A. Cook, Susan Jaken, Luna C. Musib, Roy S. Herbst, Michael Carducci, Carolyn D. Britten, Michele Basche, S. Gail Eckhardt, Donald Thornton

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-β inhibitor'. Together they form a unique fingerprint.

Medicine & Life Sciences